Search

Search Results

• 

  Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study

  Cecilia Politi, Tiziana Ciarambino, Letizia Riva, Stefania Frasson, Donata Lucci, Gualberto Gussoni, Lucio Gonzini, Mauro Campanini, Michele Gulizia, Giuseppe Di Pasquale, Giovanni Mathieu, on behalf of ATA-AF Steering Committee and Investigators

  207-212

  16-02-2016

  1639

  PDF: 1432

  Appendix: 656

  HTML: 544
• 

  Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

  Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

  314-322

  15-12-2015

  1915

  PDF: 881

  HTML: 1229
• 

  Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study

  Francesco Ventrella, Franco Mastroianni, Sergio Cappello, Luigi Iamele, Samantha Errico, Massimo Errico

  176-183

  06-07-2016

  1417

  PDF: 901

  HTML: 341
• 

  Mean platelet volume as diagnostic and therapeutic marker of risk and prognosis of heart disease

  Henshaw Uchechi Okoroiwu, Christopher Ogar Ogar

  10-14

  11-01-2018

  1615

  PDF: 719

  HTML: 642
• 

  Cryptogenic stroke

  Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei

  185-194

  30-09-2016

  1840

  PDF: 1072

  HTML: 582
• 

  Cryptogenic strokes and embolic strokes of unknown source: lights and shadows of a new construct

  Marco Masina

  171-174

  30-09-2016

  1380

  PDF: 839

  HTML: 635
• 

  Pregnancy and heart disease: what Internists should know

  Riccardo Gerloni, Domenico Panuccio

  288-304

  11-09-2017

  1269

  PDF: 641

  HTML: 263
• 

  Heart failure in real world

  Claudio Giumelli, Azio Reverzani, Riccardo Volpi, Giuseppe Chesi

  356-361

  05-10-2015

  1688

  PDF: 869

  HTML: 1306
• 

  Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

  Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

  8-21

  24-12-2013

  1273

  PDF: 839
• 

  Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

  Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, Niccolò Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

  153-169

  23-10-2012

  1631

  PDF: 1934
• 

  Antiarrhythmic or time bomb? A severe iatrogenic bradyarrhythmia

  S. Matheou, A. Reverzani, F. Dall'Orto, G. Gambarati, G. Chesi

  63-64

  03-05-2013

  901

  PDF: 1485
• 

  Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit

  Marco Masina, Annalena Cicognani, Carla Lofiego, Simona Malservisi, Riccardo Parlangeli, Alessandro Lombardi

  202-206

  30-09-2016

  1564

  PDF: 807

  HTML: 803
• 

  Management of syncope: from evidence to clinical practice

  Tiziana M. Attardo, Immacolata Ambrosino, Elena Magnani, Nathan Artom, Nicola Battino, Deasy Cervo, Massimiliano Chiuch, Mariella Frualdo, Miriam Gino, Federico Pasin, Carlo Zaninetti

  23-36

  17-06-2016

  1819

  PDF: 1226

  HTML: 1378